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Abstract. 
 
The translocation of ﬂuorescently tagged
PLC
 
g
 
 and requirements for this process in cells stimu-
lated with EGF were analyzed using real time ﬂuores-
cence microscopy applied for the ﬁrst time to monitor
growth factor receptor–effector interactions. The trans-
location of PLC
 
g
 
 to the plasma membrane required the
functional Src homology 2 domains and was not af-
fected by mutations in the pleckstrin homology domain
or inhibition of phosphatidylinositol (PI) 3-kinase. An
array of domains speciﬁc for PLC
 
g
 
 isoforms was sufﬁ-
cient for this translocation. The dynamics of transloca-
tion to the plasma membrane and redistribution of
PLC
 
g
 
, relative to localization of the EGF receptor and
PI 4,5-biphosphate (PI 4,5-P
 
2
 
), were shown. Colocaliza-
tion with the receptor was observed in the plasma
membrane and in membrane rufﬂes where PI 4,5-P
 
2
 
substrate could also be visualized. At later times, inter-
nalization of PLC
 
g
 
, which could lead to separation
from the substrate, was observed. The data support a
direct binding of PLC
 
g
 
 to the receptor as the main site
of the plasma membrane recruitment. The presence of
PLC
 
g
 
 in membrane structures and its access to the sub-
strate appear to be transient and are followed by a
rapid incorporation into intracellular vesicles, leading
to downregulation of the PLC activity.
Key words: PLC • EGF receptor • translocation •
real time imaging • SH2 and PH domains
 
Introduction
 
The hydrolysis of phosphatidylinositol 4,5-bisphosphate
(PI 4,5-P
 
2
 
)
 
1
 
 occurs in response to a large number of extra-
cellular signals to generate two second messengers: inosi-
tol 1,4,5-trisphosphate (I 1,4,5-P
 
3
 
) and diacylglycerol. In
addition, this hydrolysis may also contribute to the con-
trol of cellular PI 4,5-P
 
2
 
 levels and in this way, regulate
function of proteins that bind this lipid directly (Lee and
Rhee, 1995; Czech, 2000). Three families of mammalian
phosphoinositide-specific PLC (PI-PLC), PLC
 
b
 
 (
 
b
 
1–
 
b
 
4),
PLC
 
g
 
 (
 
g
 
1, 
 
g
 
2), and PLC
 
d
 
 (
 
d
 
1–
 
d
 
4), have been extensively
studied and characterized (Katan, 1998; Rebecchi and
Pentyala, 2000). Very recently, a new mammalian PI-PLC
sequence has been reported that represents a distinct fam-
ily of these enzymes; this PI-PLC has been designated as
PLC
 
e
 
 (Lopez et al., 2000; Song et al., 2000). Each family is
characterized by the distinct domain organization and, at
least in the case of PLC
 
b
 
 and PLC
 
g
 
 families, the type of
signaling pathway that regulates enzyme activity.
PLC
 
g
 
 is mainly regulated through receptors with intrin-
sic tyrosine kinase activity (for example, growth factor re-
ceptors) or receptors (such as B and T cell antigen recep-
tors) that are linked to the activation of nonreceptor
tyrosine kinases through a complex signaling network
(Lee and Rhee, 1995; Katan, 1998; Rebecchi and Pentyala,
2000). The two isoforms of PLC
 
g
 
 have distinct tissue dis-
tributions. Although PLC
 
g
 
1 is expressed ubiquitously, the
pattern of expression of PLC
 
g
 
2 is characterized by high
levels in cells of hematopoetic origin. Transgenic studies
suggested that the biological function of these isoforms is
reflected in their cellular distribution. Thus, the mice defi-
cient in PLC
 
g
 
1 developed normally up to embryonic day 9
when a cessation of growth occurred in all parts of the em-
bryo (Ji et al., 1997); whereas, homozygous disruption of
PLC
 
g
 
2 allowed normal development but resulted in func-
tional and signaling disorders in a subset of cell types, in-
cluding B cells, platelets, and mast cells (Wang et al.,
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3
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2000). The expression pattern together with other factors
is also likely to determine the signaling pathway to which a
specific isoform is integrated in its physiological setting.
However, in heterologous systems, PLC
 
g
 
1 and PLC
 
g
 
2
could equally fulfill the same signaling function. This has
been demonstrated in both signaling via receptor (Sultz-
man et al., 1991) and nonreceptor (DeBell et al., 1999; Ish-
iai et al., 1999) tyrosine kinases. The two isoforms share
high levels of sequence similarity, in particular in the re-
gion specific for the PLC
 
g
 
 family, which includes the
pleckstrin homology (PH) domain, two Src homology
(SH)2, and one SH3 domain (see Fig. 1).
Molecular interactions that are required for the activa-
tion of PLC
 
g
 
 have been best characterized in responses
via growth factor receptors (including receptors for EGF,
platelet-derived growth factor [PDGF], and nerve growth
factor [NGF]), where the receptor directly interacts with
PLC
 
g
 
 and phosphorylates the enzyme by the intrinsic
tyrosine kinase activity of these receptors (Lee and
Rhee, 1995; Katan, 1998; Rebecchi and Pentyala, 2000;
Schlessinger, 2000). It has been established that the sub-
cellular localization of PLC
 
g
 
 is involved in the regulation
of the enzyme activity and that translocation to membrane
structures is required for the subsequent increase in PI 4,5-
P
 
2
 
–hydrolysis. The data have also suggested that in addi-
tion to the PLC
 
g
 
 interactions with the phosphorylated ty-
rosines in the cytoplasmic part of the receptors via the
SH2 domains, other interactions with lipid membrane
components, such as phosphatidylinositol 3,4,5-trisphos-
phate (PI 3,4,5-P
 
3
 
) and/or components of the cytoskeleton,
could have an important role (Yang et al., 1994; Bae et al.,
1998; Falasca et al., 1998; Rameh et al., 1998). However,
due to the fast translocation and limitations of biochemical
approaches and immunocytochemical analysis used in pre-
vious studies, many aspects of translocation and subcellu-
lar localization of PLC
 
g
 
 have not been clarified. In partic-
ular, questions related to the type of subcellular structures
where interactions with the receptor or other targeting
molecules are taking place at different points after the ad-
dition of a growth factor and the effects of these interac-
tions on the access to its substrate and PLC activity remain
unanswered.
In this study, PLC
 
g
 
 containing a fluorescent tag was an-
alyzed in real time after stimulation of the cell with EGF.
This approach, applied for the first time in studies of
PLC
 
g
 
, circumvented many problems encountered when
using other methods. Here, we show dynamic changes in
the subcellular localization of PLC
 
g
 
 relative to the pres-
ence of EGF receptor (EGFR) and the substrate and de-
scribe possible effects of cellular localization on stimula-
tion and downregulation of the PLC activity.
 
Materials and Methods
 
Construction of Expression Plasmids
 
The construct of the PLC
 
d
 
1 PH domain and catalytically inactive PLC
 
d
 
1
with green fluorescent protein (GFP) were described previously (Takeu-
chi et al., 2000). Clones of the full-length bovine PLC
 
g
 
1 and human PLC
 
g
 
2
in the pMT2 vector have been described previously (Sultzman et al., 1991)
and were used to make several more constructs. The DNA fragments of
PLC
 
g
 
1 and PLC
 
g
 
2 corresponding to the NH
 
2
 
-terminal PH domains (en-
coding residues 14–150 for PLC
 
g
 
1 and 8–144 for PLC
 
g
 
2 and extended
constructs encoding residues 1–309 for PLC
 
g
 
1 and 1–301 for PLC
 
g
 
2) and
 
g
 
SA regions (encoding residues 484–936 for PLC
 
g
 
1 and 468–919 for
PLC
 
g
 
2) were amplified by PCR. Each fragment was subcloned into the
GFP fusion protein expression vector pEGFP-C1 (CLONTECH Labora-
tories, Inc.) using the BglII and EcoRI restriction sites. Specific domain ar-
ray (SA) region of PLC
 
g
 
2 was also subcloned into pDsRed-C1 vector
(CLONTECH Laboratories, Inc.), which produces a red fluorescent pro-
tein (RFP) using the BglII and EcoRI sites. Mutated 
 
g
 
SA regions with the
Arg 564 to Ala (R564A) replacement within the N-SH2 domain or Arg
672 to Ala (R672A) replacement within the C-SH2 domain in PLC
 
g
 
2 were
generated using two-stage PCR-based overlap extension method. Forward
mutagenesis primers were: 5
 
9
 
-CTGGTTGCGGAGAGCGAGAC for
R564A and 5
 
9
 
-TCCTGATCGCGAAGCGAGAGG for R672A. The
PCR products were subcloned into pEGFP-C1 vector using the BglII and
EcoRI sites and the sequences verified. The full-length cDNAs of PLC
 
g
 
1
and PLC
 
g
 
2 were subcloned into pDsRed-N1 vector (CLONTECH Labo-
ratories, Inc.) using Eco47III and BamHI sites (pDsRed vector), NotI
(filled in by mungbean nuclease [New England Biolabs, Inc.]), and
BamHI. The constructs of R564A replacement in the context of the full-
length was made by replacing a part of the wild-type 
 
g
 
SA region with mu-
tated fragments of the same region using XmnI and SacII restriction sites.
For the expression in DT40 cells, the full-length cDNA of PLC
 
g
 
2 was also
inserted into pApuro vector (Takata et al., 1994) using EcoRI and KpnI
sites. The acidic or alanine mutants of the NH2-terminal PH domain (resi-
dues 56KTADK60 to either KDDDE or AAAAA) in PLC
 
g
 
2–pDsRed
and –pApuro constructs were made by replacing the wild-type PH domain
region with the mutated fragments generated by the PCR-based mutagen-
esis described above, using EcoRI sites. The forward mutagenesis primers
were: 5
 
9
 
-TGGAGCAAGGACGACGACGAGATCGAG for acidic sub-
stitutions and 5
 
9
 
-TGGAGCGCGGCCGCCGCCGCGATCGAG for ala-
nine substitutions. The deletion mutant of the PH domain in the full-
length PLC
 
g
 
2 construct was made by exchanging the PH and EF hand
regions with only the EF hand region, which was amplified by PCR and
subcloned using EcoRI sites, thus generating construct encoding amino
acid residues 134–1256 of PLC
 
g
 
2. The EGFR–GFP construct was de-
scribed previously (Wouters and Bastiaens, 1999) and used to generate an-
other EGFR construct by replacing the GFP coding region (NotI restric-
tion site was generated by filling in the cleaved PvuI site) with the RFP
coding region from pDsRed vector (NotI restriction site was generated by
filling in the cleaved BamHI site). Sequences of all fragments generated by
PCR were verified by dideoxynucleotide sequencing.
 
Cell Culture and Transfection
 
A431 and COS-7 cells were cultured in DME supplemented with 10%
FBS. The transfection of GFP or RFP fusion protein constructs were
made using cells in a 60-mm dish (Nunc), a glass-bottomed 50-mm dish
(MatTek Corporation), or on 22-mm-diameter coverslips (British Drug
House)
 
 
 
using 2.0, 0.4, or 0.8 mg of plasmid DNA, respectively, and Lipo-
fectAMINE Plus reagent (GIBCO BRL) according to the manufacturer’s
instructions. 0.2 mg of each DNA was used in cotransfection of EGFR and
PLC
 
g
 
 constructs on a 60-mm dish with a coverslip at the bottom. After
24 h, cells were serum starved overnight in DME with 1% FBS before
EGF stimulation. PC-12 cells were cultured and stimulated with NGF as
described previously (Takeuchi et al., 2000).
DT40 cells (chicken B–lymphoma cell lines), the wild-type and PLC
 
g
 
2-
deficient (Takata et al., 1995), were maintained in RPMI 1640 medium
supplemented with 10% FBS and 1% chicken serum at 40
 
8
 
C. Stable trans-
fectants of those DT40 cells were generated as described (Takata et al.,
1995). In brief, the linearized wild-type or mutant constructs of PLC
 
g
 
2
were introduced into DT40 PLC
 
g
 
-deficient cells by electroporation
(950 V, 25 
 
m
 
F,
 
 ` V
 
, Gene Pulser; Bio-Rad Laboratories). After 1 d, puro-
mycin (0.35 
 
m
 
g/ml) (Sigma-Aldrich) was added to the medium. 10–12 d af-
ter the selection, colonies were picked, and the puromycin (0.2 
 
m
 
g/ml) se-
lection was repeated for 5–8 d. Subsequently, the puromycin-resistant
colonies were grown in normal medium for a further 5 d or until cells were
growing normally.
 
Confocal Microscopy
 
To visualize responses to EGF, the transfected cells were serum-starved
overnight in the presence of 1% FBS. The medium of cells cultured in
glass-bottomed 50-mm dishes (MatTek Corporation) was subsequently
changed to HBSS without phenol-red (GIBCO BRL). EGF (Becton
Dickinson) was added at a concentration of 100 ng/ml. For the treatment 
Matsuda et al. 
 
Imaging of PLC
 
g
 
 Translocation
 
601
 
with LY294002, the cells were incubated with 2–50 
 
m
 
M LY294002 (Cal-
biochem) for 40 min at 37
 
8
 
C before the addition of EGF.
Intracellular localization of fluorescent fusion proteins in living cells
was performed on a Bio-Rad Laboratories MRC1024 confocal imaging
system in conjunction with a Nikon Eclipse 600 microscope and Lazer-
Sharp software. Detection of GFP and RFP was carried out using a kryp-
ton-argon laser together with standard FITC and Texas red filter sets. The
cells were imaged using a 60
 
3
 
 plan-apo oil immersion objective. The im-
ages were recorded in 5-s intervals. The cells were analyzed at room tem-
perature immediately after being taken out from the 37
 
8
 
C incubator. The
white bars in the figures indicate 10 
 
m
 
m.
For further analysis of images, we used several programs in the Laser-
Pix (version 4.0) package (Bio-Rad Laboratories) including intensity/opti-
cal density analysis, relative quantitation, and timecourse analysis. For sin-
gle cells, cross section areas have been selected; whereas, for the fields of
cells all areas of the cytoplasm and plasma membrane (corrected for the
fluorescence contributed by the cytoplasm) have been used to calculate
average intensities at different timepoints.
The cell staining using antibody to PI 4,5-P
 
2
 
 (Fukami et al., 1988)
(shown not to cross react with phosphatic acid, cardiolipin, phosphati-
dylserine, phosphatidylethanolamine, phosphatidylcholine, PI, or PI-
monophosphate [Fukami et al., 1988] and had only 
 
z
 
10–20-fold lower
binding to much less abundant PI P
 
3
 
) was as follows: after stimulation with
EGF, the cells were fixed in 0.4% formaldehyde for 10 min; the cells were
permeabilized for 10 min with 100 mM glycine, 0.1% Triton X-100 after
which nonspecific binding was blocked by incubating for 5 min in 0.1%
BSA in PBS; anti–PI 4,5-P
 
2
 
 antibody (1:100) was added for 1 h at room
temperature; after washing, the Texas red or FITC-conjugated antibody
was added for 30 min at room temperature; and the cells were then
washed, mounted, and viewed by confocal microscopy.
 
Measurement of Intracellular Calcium Concentration
 
The method used to measure intracellular calcium concentrations was ac-
cording to Lawrence et al. (1998). In brief, serum-starved, transfected, or
nontransfected COS-7 or A431 cells on coverslips were washed with PBS
and incubated with 25 mM Hepes-buffered (pH 7.0) DME, 4 
 
m
 
M Fura-
2AM or Fura-red AM (Molecular Probes), and 5 
 
3
 
 10
 
2
 
4
 
% Pluronic F-127
(Molecular Probes) for 30 min at room temperature and another 30 min at
37
 
8
 
C. After a wash with PBS, the cells on coverslips were placed onto the
microscope chamber, which was kept at 37
 
8
 
C, and covered with 25 mM
Hepes-buffered (pH 7.0) DME. The fluorescence was measured using epi-
fluorescence optics on a Nikon Diaphot inverted microscope fitted with a
CCD camera. Intracellular calcium level is expressed as the ratio of fluo-
rescence at 340:380 nm (Fura-2AM) or 440:490 nm (Fura-red).
For measurements of intracellular calcium concentrations in DT40
cells, a cell suspension containing 5 
 
3
 
 10
 
6
 
 cells was loaded with 2 
 
m
 
M
Fluo-3AM (Molecular Probes) for 1 h at room temperature. After the
cells were washed with PBS, their calcium mobilization was measured at
40
 
8
 
C after stimulation with 10 
 
m
 
g/ml goat anti–chicken IgM, using a stirred
suspension of cells in a LS-50B fluorimeter (PerkinElmer). The excitation
was at 490 nm, and the emission was monitored at 535 nm.
 
Analysis of the Protein Expression and Phosphorylation 
by Western Blotting and/or Immunoprecipitation
 
Transfected COS-7 or A431 cells were harvested and resuspended in PBS
buffer containing a protease inhibitor cocktail (Boehringer), sonicated,
and subjected to centrifugation at 35,000 
 
g
 
. Aliquots of the supernatants
were separated by SDS-PAGE, transferred to polyvinyldifluoride mem-
branes, and the membrane incubated with the appropriate primary and
secondary antibodies. The anti-PLC
 
g
 
1 antibody (1:3,000; Upstate Bio-
technology) and anti-PLC
 
g
 
2 antibody (1:4,000; Santa Cruz Biotechnol-
ogy, Inc.) were used to analyze the expression of all full-length PLC
 
g
 
 con-
structs. The anti-GFP antibody (1:2,500; CLONTECH Laboratories, Inc.)
was used to analyze the expression of the GFP–N-PH or 
 
g
 
SA fusion
proteins. The detection of PLC
 
g
 
1 phosphorylation was performed with
anti-PLC
 
g
 
1(pY783) phosphospecific antibody (1:2,000; BioSource Inter-
national), whereas phosphorylation of PLC
 
g
 
2 was monitored after immu-
noprecipitation (incubation with protein G–agarose-conjugated anti-
PLC
 
g
 
2 antibody for 1.5 h at 4
 
8
 
C) using antiphosphotyrosine antibody
(1:1,000; Transduction Laboratories). In both cases, cellular extracts were
prepared in the presence of 0.5% NP-40. The blots were visualized using
ECL system (Amersham Pharmacia Biotech).
The detection of phosphorylated EGFR and protein kinase B (PKB)
proteins in A431 cells was performed before and after EGF stimulation of
cells preincubated in the presence or absence of LY294002 as described
above. The stimulation was terminated by washing with ice-cold PBS. Cell
lysates were prepared using a lysis buffer (10 mM Tris-HCl, pH 7.4, 150
mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100, 0.2 mM PMSF,
0.5% NP-40, protease inhibitor cocktail, and phosphatase inhibitor cock-
tail) (Sigma-Aldrich) and the clarified lysates separated by SDS-PAGE
and analyzed by Western blotting. The antiphosphotyrosine antibody
(1:1,000; Transduction Laboratories) or antiphospho–PKB/Akt (Serine
473) antibody (1:1,000; New England Biolabs, Inc.) were used, followed
by the incubation with an appropriate secondary antibody (anti–rabbit Ig
HRP-linked whole antibody or anti–mouse Ig HRP-linked whole anti-
body, diluted 1:3,000) (Amersham Pharmacia Biotech).
 
Results
 
Translocation of PLC
 
g
 
 to the Plasma Membrane: 
An Essential Role of the SH2 Domains
 
To analyze the cellular localization of PLC
 
g
 
1 and PLC
 
g
 
2
in real time, molecules incorporating green (GFP) or red
(RFP) fluorescence tags (placed either at the COOH or
NH
 
2
 
 terminus of PLC) were constructed. The expression
of all constructs in COS-7 or A431 cells resulted in the ap-
pearance of proteins of expected size (z170 kD). The con-
structs used in most of the experiments described here,
which have an RFP tag at the COOH terminus of PLCg
(PLCg1-RFP and PLCg2-RFP), are shown in Fig. 1. Mea-
surements of in vitro PLC activity in the extracts of trans-
fected cells confirmed that the constructs encoded enzy-
matically active PLCg1 and PLCg2. The cell line that has
been chosen to monitor cellular localization was A431-epi-
dermoid carcinoma cell line, where the number of recep-
tors responding to EGF is increased. Using biochemical
methods, it has been shown previously that endogenous
PLCg1 in this cell line redistributes from the cytosolic
fraction to membrane fractions within minutes of EGF
stimulation (Todderud et al., 1990). As shown in Fig. 2, in
the absence of EGF, PLCg1 and PLCg2 were distributed
throughout the cytoplasm and excluded from the nucleus
and plasma membrane. After addition of EGF, the trans-
location to the plasma membrane was largely completed
within 2–3 min for both PLCg1 and PLCg2 and was ac-
companied by a reduction of fluorescence in the cytoplasm
(Fig. 2). This similarity between PLCg1 and PLCg2 trans-
location is consistent with previous comparisons of the two
isoforms in growth factor signaling (Sultzman et al., 1991).
These studies have shown that the hydrolysis of PI 4,5-P2
in response to PDGF mediated by PLCg1 in fibroblasts,
was enhanced in cells overexpressing either PLCg1 or
PLCg2; both enzymes could undergo phosphorylation by
and interaction with the receptor. Further analysis of re-
cordings shown in Fig. 2 taken in 5-s intervals, revealed
some differences between individual cells. However, in
most cells the appearance of PLCg in some parts of the
membrane could be detected after 10–30 s. The area of the
membrane where PLCg was present increased with time
to cover most of the membrane surface. In the majority of
cells, some further increases in the membrane recruitment
could be seen between 2 and 3 min. This is illustrated in
Fig. 2 C and also by the kinetic analysis in Fig. 2 D, using
PLCg2 construct. The kinetic studies of translocation per-
formed on fields of cells were consistent with the main
conclusions described above, without significant differ-
ences observed between the two isoforms.The Journal of Cell Biology, Volume 153, 2001 602
Several domains, including the PH domain at the NH2
terminus (N-PH), two SH2 domains (N-SH2 and C-SH2),
and the SH3 domain, have been implicated in subcellular
targeting of PLCg isozymes. The importance of the SH2
domains has been best documented and related to interac-
tions with the receptor or adapter proteins (Lee and Rhee,
1995; Katan, 1998; Rebecchi and Pentyala, 2000). The re-
gion specific for the PLCg family (“g-specific array,”
[gSA]) incorporates most of the domains that could play a
role in translocation. The constructs of PLCg1 and PLCg2
containing only this region with the GFP tag placed at the
NH2 terminus (GFP-g1SA and GFP-g2SA) have been
made and found to express proteins of the predicted size
(Fig. 1). These constructs, in most cells, completed translo-
cation to the plasma membrane within 2–3 min (Fig. 3, A
and B); these similar timecourses were further supported
by kinetic studies, when giving an average translocation
for a field of cells (Fig. 3 D). However, as observed with
the full-length constructs not all cells responded uni-
formly. In Fig. 3 C, two cells from the same field were se-
lected to illustrate these differences. In one cell, the inter-
action that spread all over the membrane surface could be
seen after 3 min; whereas, in the other it was completed af-
ter z1 min, followed by extensive membrane ruffling (see
2 and 3 min timepoints). The extensive membrane ruffling
could be seen in some but not all cells responding to EGF
and was usually prominent at later timepoints.
To further analyze which domains within the gSA re-
gion could be involved in translocation, point mutations
were introduced into the N- and C-SH2 domains. Replace-
ments of Arg586 (N-SH2) and Arg694 (C-SH2) in PLCg1
and Arg564 (N-SH2) and Arg672 (C-SH2) in PLCg2 have
been shown previously to interfere with the function of
these enzymes (Chattopadhyay et al., 1999; DeBell et al.,
1999; Ishiai et al., 1999; Ji et al., 1999; Poulin et al., 2000).
Both SH2 domains are highly conserved between the two
isozymes (93% similarity). The mutation Arg564Ala or
Arg672Ala, introduced in the context of GFP-g2SA or
Figure 1. Constructs of PLCg and
their expression as fluorescent-tagged
proteins. (A) The domain organization
of PLCg shows two parts: PLC core
which includes the NH2-terminal PH
domain (light blue), EF hands, cata-
lytic (X and Y regions) and C2 do-
mains (dark blue), and PLCg-specific
domain array (gSA) (orange) incorpo-
rating the “split” PH domain, two SH2
domains (N-SH2 and C-SH2), and the
SH3 domain. (B) Schematic represen-
tation of the full length, deletion, and
point mutations of PLCg1 and g2. The
regions are color-coded as described in
A. The amino acid residues encom-
passing each construct of are shown,
and positions of point mutations are in-
dicated (X). (C) The expression of dif-
ferent constructs have been analyzed
by Western blotting of the high speed
supernatant fraction prepared from
transfected COS-7 cells. (Left) RFP fu-
sion proteins of the full-length PLCg1
(lane 1), PLCg2 (lane 2), PLCg2 with
acidic substitutions (lane 3), or alanine
substitutions (lane 4) in the PH do-
main, the deletion of the PH domain in
PLCg2 (lane 5), and R564A mutant in
the context of the full-length PLCg2
(lane 6). The RFP is present at the
COOH terminus of these constructs.
(Middle) GFP fusion proteins of the
N-PH from PLCg1 (lane 1) and PLCg2
(lane 2). The GFP tag is present at the
NH2 terminus. (Right) GFP fusion
proteins of gSA region from PLCg1
(lane 1) and PLCg2 (lane 2) and g2SA
constructs incorporation mutations
R564A (lane 3) or R672A (lane 4).
The GFP fusion protein constructs
have the GFP tag at the NH2 terminus.
Similar results were obtained from
analysis of transfected A431 cells; how-
ever, expression levels were lower.Matsuda et al. Imaging of PLCg Translocation 603
PLCg2-RFP (GFP-g2SA R564A, GFP-g2SA R672A, and
PLCg2 R564A-RFP), did not reduce protein expression
(Fig. 1). As shown in Fig. 4, these mutations completely
prevented translocation to the membrane after the addi-
tion of EGF.
Analysis of Requirements for the 
NH2-terminal PH Domain
To assess the role of the PH domain in the translocation of
PLCg, this domain from both PLCg1 and PLCg2 was ex-
pressed in isolation as a GFP fusion protein (GFP-g1N-
PH and GFP-g2N-PH) (Fig. 1). In addition, the deletion
and point mutations within the NH2-terminal PH domain
have been introduced in the context of the full-length
PLCg2 protein (Fig. 1). When analysis of the isolated
PLCg PH domains was performed, the PH domain
from PLCd1 was used for comparison. As shown previ-
ously in several cell types (Katan and Allen, 1999), the
PLCd1 PH domain associated with the membrane of un-
stimulated cells (Fig. 5 A). In contrast, GFP-g1N-PH and
GFP-g2N-PH were not present at the membrane of un-
stimulated cells and the staining observed in the cytoplasm
and nucleus; the later was more prominent for the GFP-
g2N-PH. After EGF stimulation, the PH domain con-
structs could be seen associated with the membrane (Fig. 5
A) as observed previously for the PLCg1 PH domain in
PDGF-treated fibroblasts (Falasca et al., 1998). However,
the membrane association could be seen in some but not
Figure 2. Translocation of the
full-length PLCg1- and PLCg2-
RFP proteins after EGF stimu-
lation of A431 cells. A431 cells
were transiently transfected
with PLCg1-RFP or PLCg2-
RFP fusion construct. The im-
ages of PLCg1-RFP (A) and
PLCg2-RFP (B) were taken
from a real time recording be-
fore (left) and 3 min after stimu-
lation with 100 ng/ml of EGF
(right). The relative fluores-
cence intensity shown in A and
B has been obtained from the
LaserPix analysis of cross sec-
tions of single cells (before and
after stimulation); for clarity,
the site used for analysis is indi-
cated (*) in fields of unstimu-
lated cells. Vesicular structures
observed in some cells (visible in
A) were not related to the ex-
pression of a particular construct
or EGF stimulation. (C) Images
from different timepoints of
translocation of PLCg2-RFP.
(D) The kinetic analysis of trans-
location has been performed us-
ing 5–10 cells from the same dish
and an average ratio of intensity
in the areas of the plasma mem-
brane (Ipm) and cytoplasm
(Icyt) shown for every fourth
frame of the recordings. The
graph illustrates translocation of
PLCg2-RFP with the points
within an error of 620%. The
data for PLCg1-RFP fit a similar
curve. Several cells that signifi-
cantly differ from this average
have not been analyzed. Typi-
cally, 50–70% of the protein
translocated. Bar, 10 mm. The Journal of Cell Biology, Volume 153, 2001 604
all cells that express these constructs (Fig. 5 A, middle and
bottom right panels). Furthermore, this membrane local-
ization was most prominent after 8 min, later than ob-
served for the full-length proteins or the gSA constructs.
For further analysis, we attempted to introduce deletion
and point mutations of the PH domain in the context of
the full-length protein. Attempts to delete the PH domain
of PLCg2 proved incompatible with the expression of the
soluble functional protein (it was exclusively in the pellet
and inactive), suggesting its essential structural role. In-
stead, mutations were introduced in the PH domain based
on a previous study, restricted to the isolated PH domain
of PLCg1 (Falasca et al., 1998). It has been reported that
the replacement of several residues within the b3–b4 loop
(to create a region of negative charges) prevented PDGF-
induced and wortmannin-sensitive association with the
membrane in cells and the specific binding of the PI 3,4,5-
P3 headgroup by the isolated PH domain in vitro (Falasca
et al., 1998). Since PLCg1 and PLCg2 have similar se-
quences and identical positions of positively charged resi-
dues in this region, the same replacement has been in-
troduced (57TADK60 replaced by 57DDDE60) into the
full-length PLCg2; in addition, the alanine substitutions
have also been made (mutation of 56KTADK60 to
56AAAAA60). Unlike the deletion of the PH domain,
the expression of these mutants (PHacPLCg2-RFP and
PHalaPLCg2-RFP) was the same as for the wild-type
PLCg2 (Fig. 1). The translocation of PLCg2 incorporating
the substitutions in the N-PH was analyzed after stimula-
tion of A431 cells with EGF. The membrane translocation
of the wild type and the proteins incorporating the muta-
tions could be clearly seen 3 min after stimulation. This is
illustrated by the acidic substitution in Fig. 5 B. Further ki-
netic analysis did not show any substantial changes (not
shown). Tyrosine phosphorylation of these mutants was
also comparable with the wild-type construct (Fig. 6 B),
Figure 3. Translocation of g-spe-
cific domain array from PLCg1
and PLCg2 in A431 cells after
EGF stimulation. A431 cells
were transfected with constructs
containing g-specific array of do-
mains and analyzed before and
after stimulation with EGF (100
ng/ml). The images show cells
transfected with GFP-g1SA (A)
and GFP-g2SA (B) constructs
before (left panels) and 2 min
after stimulation with EGF
(right panels). The different
timecourses of GFP-g2SA
translocation in two cells from
the same field are shown in C.
The relative fluorescence inten-
sity of selected cross sections in
A and B and the kinetic study of
an average translocation illus-
trated by GFP-g2SA (D) was
analyzed as described in the leg-
end to Fig. 2. Bars, 10 mm.Matsuda et al. Imaging of PLCg Translocation 605
and based on the analysis of PLCg1 constructs where se-
quence specific antiphosphotyrosine antibody is available
(Fig. 6 A), the phosphorylation is likely to occur at physio-
logically relevant sites.
Finding that the N-PH domain may not play a role in the
initial translocation to the membrane suggested that it
could be important for some other steps involved in the
stimulation of PLCg. To test this, we used a PLCg-defi-
cient B cell line (PLCg22/DT40). After stimulation of B
cell antigen receptor, an increase in intracellular free Ca21
concentrations has been attributed to highly expressed
PLCg2 in normal B lymphocytes (Wang et al., 2000). This
can be reconstituted by either PLCg1 or PLCg2 in the
PLCg22/DT40 cells (DeBell et al., 1999; Ishiai et al., 1999).
Furthermore, it has been shown that N- or C-SH2 mutants
in either isozyme were not able to restore the function of
PLCg in these cells (DeBell et al., 1999; Ishiai et al., 1999).
As expected, the wild-type PLCg2 fully restored the cal-
cium responses in PLCg22/DT40 cells stably transfected
with this construct (Fig. 5 C, right). Analysis of the stable
cell lines obtained with the full-length constructs incorpo-
rating mutations within the PH domain (PHacPLCg2 and
PHalaPLCg2), demonstrated the same calcium responses
as seen with the wild-type PLCg2 (Fig. 5 C, right). The
same experimental system, stimulation of DT40 cells with
the M4 antibody, was used to test a possible dominant-neg-
ative function of the isolated PH domain, which has been
suggested in previous studies using fibroblasts stimulated
with PDGF (Falasca et al., 1998). As shown in Fig. 5 C
Figure 4. Mutations in the SH2 domains. The effects of muta-
tions in N-SH2 or C-SH2 domain were analyzed using
PLCg2R564A-RFP, GFP-g2SA R564A, and GFP-g2SA R672A
constructs 3 min after EGF stimulation. (A) The images show
cellular localization of PLCg2-RFP containing the wild-type se-
quences (left) compared with PLCg2R564A-RFP (right). (B)
Cellular localization of the wild-type GFP-g2SA (left), GFP-
g2SA R564A (middle), and GFP-g2SA R672A (right) con-
structs. Bars, 10 mm.
Figure 5. Analysis of the NH2-terminal PH domain of PLCg. (A)
Cells were transfected with GFP fusion constructs of isolated PH
domains from PLCd1 (top), PLCg1 (middle), or PLCg2 (bottom)
and analyzed before (left) or 5–8 min after stimulation with EGF
(right). (B) Effect of the acidic substitutions in the PLCg2 PH do-
main on membrane localization was analyzed using the full-length
PLCg2 constructs. The images show a comparison of PLCg2-RFP
(top) and PHacPLCg2-RFP (bottom) analyzed before (left) and 2
min after (right) addition of EGF. (C) Several DT40 cell lines
were used to measure calcium responses after stimulation with
M4 antibody (10 mg/ml). (Left) The wild-type DT40 cells (con-
trol) and the wild-type cells stably transfected with the g2 N-PH-
GFP (1PH) construct; (right) the PLCg2-deficient cells (control)
and the PLCg2-deficient cells stably transfected with the full-
length PLCg2 (1g2) or the full-length constructs with the acidic
(1PHac) or alanine (1PHala) mutation in the PH domain. Bar,
10 mm.The Journal of Cell Biology, Volume 153, 2001 606
(left), in DT40 cells stably expressing GFP-g2N-PH (lane
2), the calcium responses were comparable with the re-
sponses in the wild-type DT40 cells (lane 1).
Colocalization of PLCg with the EGFR Visualized 
Using Red and Green Fluorescent Tags
The GFP-tagged EGFR construct (EGFR-GFP) used in
this study, has been analyzed previously and shown to en-
code a stable protein that undergoes phosphorylation and
internalization after stimulation of transfected COS cells
with EGF (Wouters and Bastiaens, 1999). The red tag ver-
sion (EGFR-RFP) was also made by replacing the GFP
portion at the COOH terminus of the EGFR construct.
These constructs were used to compare the localization of
EGFR with that of the full- length or g-specific domain ar-
ray of PLCg2, using a combination of red and green fluo-
rescent tags expressed in the same cell.
Cells coexpressing the EGFR-RFP and the array of do-
mains from PLCg2 as a GFP fusion protein, g2SA-GFP,
were analyzed first (Fig. 7). Before stimulation, EGFR-
RFP was present at the plasma membrane (Fig. 7 A, right,
top and bottom). Although high levels of expression of the
GFP-g2SA construct could be seen throughout the cyto-
plasm of COS-7 cells, the plasma membrane association
could not be detected before EGF stimulation (Fig. 7 A,
left, top and bottom). The merge of the enlarged areas was
red due to presence of only the EGFR fluorescent tag. Af-
ter stimulation, the GFP-g2SA construct first appeared in
some parts of the membrane (similar to distribution in
A431 cells in Fig. 2) and spread across the membrane sur-
face within 1 min (Fig.7 B, left, top and bottom). As seen
in the merge, the membrane color has become yellow, due
to colocalization with the green fluorescence from g2SA-
GFP after EGF stimulation. Similar translocation and
membrane colocalization after the EGF treatment have
been observed in cells expressing red-tagged receptor and
green full-length PLCg2 or the EGFR-GFP and PLCg2-
RFP constructs. In the later case, the color of the merge
was changed from green to yellow (data not shown). 
In some cells and in particular at later timepoints after
stimulation, extensive ruffling could be observed. In cells
where ruffling was prominent, the EGFR distribution (fol-
lowed by the green fluorescent tag) appeared to be un-
even, with the majority of the receptor present in areas of
membrane ruffles (Fig. 8 A). Distribution of the full-
length PLCg2 (with the red fluorescence tag) in the same
cell demonstrated that PLCg2 was localized in areas
where EGFR was present. However, PLCg2-RFP did not
cover all areas of the membrane where EGFR-GFP could
be detected, and as seen in Fig. 8 A some areas contained
only EGFR. However, it is difficult to distinguish between
different possibilities that could explain this distribution.
The possibilities include complex formation in “preferred”
areas of the membrane or a quick dissociation and sepa-
rate internalization of PLCg2.
The internalization of the EGFR and PLCg2, coex-
pressed in a single cell, could also be studied after EGF
stimulation. The appearance of small intracellular vesicles
could be seen within minutes after stimulation (Fig. 8 A),
which subsequently increased in size (Fig. 8 B); this was vi-
sualized for both EGFR-GFP (right, top and bottom) and
PLCg2-RFP (left, top and bottom). As shown in Fig. 8 B,
z15 min after EGF stimulation, most of the EGFR was as-
sociated with the migrating intracellular vesicles shown
previously to represent endosomes undergoing fusion and
forming vesicular swellings (Carter and Sorkin, 1998).
Some receptor also localized at the membrane (Fig. 8 B,
right, top and bottom). At the same time, PLCg2 was en-
tirely associated with the intracellular vesicles (Fig. 8 B,
left, top and bottom). Further analysis of the areas con-
taining the intracellular vesicles revealed colocalization of
PLCg2-RFP and EGFR-GFP constructs in many of these
structures. However, some vesicles seem to contain only
EGFR or only PLCg2. These data suggest that the inter-
nalization paths of EGFR and PLCg2 could be, at least in
part, separate.
Localization of PI 4,5-P2
In addition to biochemical studies, the metabolism and lo-
calization of PI 4,5-P2 have been monitored using reagents
that specifically bind to this inositol lipid. In particular, the
PH domain of PLCd1 has been shown to bind PI 4,5-P2
present in the plasma membrane (Katan and Allen, 1999).
Using GFP constructs of the isolated PLCd1 PH domain
(or the catalytically inactive full-length PLCd1), the mem-
brane localization could be seen before and after stimula-
tion with EGF (Fig. 5 A). Antibody specific to PI 4,5-P2 was
also used, and in this case the staining was more clearly
Figure 6. Phosphorylation of PLCg1 and PLCg2 constructs after
EGF stimulation. Transfected COS-7 cells were incubated with or
without EGF (100 ng/ml) for 5 min, and cell lysates were either
analyzed by Western blotting with anti-PLCg1(pY783) antibody
when PLCg1 constructs were used or subjected to immunoprecip-
itation with anti-PLCg2 antibody followed by Western blotting
with antiphosphotyrosine antibody for PLCg2 constructs. (A)
Nontransfected (lanes 1 and 2) and cells transfected with PLCg1-
RFP (lanes 3 and 4) or GFP-g1SA (lanes 5 and 6) were analyzed
before (lanes 1, 3, and 5) or after (lanes 2, 4, and 6) EGF stimula-
tion. In the case of GFP-g1SA, some phosphorylation could be
seen before EGF stimulation but was clearly stimulated after the
addition of the agonist. (B) RFP fusion proteins of the full-length
PLCg2, the wild-type (lanes 1 and 2), acidic mutant in the PH do-
main (lanes 3 and 4), and alanine mutant in the PH domain (lanes
5 and 6) were analyzed before (lanes 1, 3, and 5) and after (lanes
2, 4, and 6) EGF stimulation.Matsuda et al. Imaging of PLCg Translocation 607
seen in the membranes of stimulated cells. In addition,
staining of perinuclear area and Golgi could be seen in
some cells using the antibody and was not strictly depen-
dent upon cell stimulation (Fig. 9, A and B). As reported
previously (Varnai and Balla, 1998), these intracellular
structures could also be visualized by the PLCd1 PH do-
main, but its localization was less prominent in these struc-
tures than in the plasma membrane. This difference could
be due to the different affinities or accessibility of the two
probes. Nevertheless, in cells with membrane ruffles where
the distribution of GFP-PLCd1 was uneven it could be
clearly seen that staining with the antibody to PI 4,5-P2
completely colocalized with the green fluorescence in these
structures. As shown in Fig. 9 C, at the timepoints when
some of the PLCg remained on the membrane although the
larger portion has been internalized into intracellular vesi-
cles, PI 4,5-P2 and PLCg colocalized only at the membrane.
This can be concluded from direct comparisons of PLCg
distribution and staining with anti–PI 4,5-P2 antibody in the
same cell (Fig. 9 C) and from observations that PLCd1 (the
full-length or the PH domain) or the antibody to PI 4,5-P2
did not show internalization into intracellular vesicles at
times when PLCg was present in this compartment. This
suggests that after internalization, PI 4,5-P2 was not avail-
able to PLCg, even if the enzyme could still be phosphory-
lated and/or present in a complex with the receptor.
In agreement with previous observations (Varnai and
Balla, 1998), our analysis of the localization of the PLCd1
PH domain did not reveal detachment of this domain from
the membrane at times (1–2 min) of I 1,4,5-P3 formation
and calcium release triggered by growth factors (data not
shown). This could be due to a smaller portion of PI 4,5-P2
hydrolyzed when compared with the system where the de-
tachment could be seen (Varnai and Balla, 1998) or, as
suggested in HeLa cells stimulated by EGF, due to a rapid
stimulation of PI 4,5-P2 resynthesis by growth factors
(Honda et al., 1999).
Effects of the PI 3-Kinase Inhibitor LY294002
The effects of PI 3-kinase inhibitors, wortmannin, and a
more specific LY294002 compound on I 1,4,5-P3 formation
and calcium mobilization have been observed after PDGF
stimulation, resulting in the reduction of these responses
(Bae et al., 1998; Falasca et al., 1998; Rameh et al., 1998).
Furthermore, it has been suggested that the products of PI
3-kinase could affect PLCg1 activity and bind to the N-PH
domain and/or C-SH2 domain (Bae et al., 1998; Rameh et
al., 1998). However, the inhibition of PI 3-kinase had no
effect on PLCg1 phosphorylation and the receptor binding
(Falasca et al., 1998; Rameh et al., 1998). To examine the
effect of LY294002 compound on PLCg translocation, we
first analyzed inhibition of phosphorylation of PKB within
the range commonly tested in cells (0–50 mM) and dem-
onstrated that even higher concentrations (50 mM) did
not inhibit EGFR phosphorylation nonspecifically, which
would otherwise interfere with the translocation (Fig. 10
A). Even with higher concentrations of LY294002, trans-
Figure 7. Analysis of PLCg2
colocalization with the EGFR.
Localization of gSA region and
EGFR is shown for a timepoint
before (A) and 1 min after (B)
EGF stimulation. COS-7 cells
were cotransfected with GFP-
g2SA and EGFR-RFP and ana-
lyzed for green (left) and red
(right) fluorescence. A selected
area (white rectangle) has been
enlarged and in addition to im-
ages obtained by analyzing only
green (left) and red (right) fluo-
rescence includes a merge (mid-
dle) of the two. Bar, 10 mm.The Journal of Cell Biology, Volume 153, 2001 608
location of PLCg2-RFP to the membrane could be seen
(Fig. 10 B, left) and was comparable to the timecourse of
translocation in untreated cells. Similarly, no effect of
LY294002 has been seen on the translocation of GFP-g1
and -g2SA or g1- and g2N-PH constructs (data not
shown). Furthermore, the appearance of PI 4,5-P2 in mem-
brane ruffles was also unaffected by LY294002 treatment
(Fig. 10 B, right).
The calcium responses to the stimulation by a growth
factor (for example, PDGF) could usually be detected af-
ter 20–40 s with a duration of 2–3 min (Rameh et al., 1998;
Poulin et al., 2000). Similar responses were detected using
EGF stimulation of A431 (Fig. 10 C) or COS-7 cells (data
not shown). Reduction in calcium responses to EGF stim-
ulation could also be detected in these cells in the presence
of 10 mM LY294002, but the effect was more pronounced
at 50 mM LY294002 (that is, reduced further from z20 to
50%) (Fig. 10 C). Since inhibition of PI 3-kinase activity
(shown by PKB phosphorylation, Fig. 10 A) seems to be
complete at 10 mM LY294002, it is possible that the bind-
ing to other targets could be responsible for the effects on
calcium responses using 50 mM LY294002.
Figure 8. Internalization of PLCg2
and EGFR after stimulation with the
EGF. COS-7 cells were cotransfected
with the full-length PLCg2-RFP and
EGFR-GFP constructs, and the same
cells were analyzed for red (left) and
green (right) fluorescence. Images
taken from the real time recording cor-
respond to 2 min (A) and 15 min (B)
timepoints after addition of EGF. For
the enlarged areas, the merge of red
and green fluorescence is shown in the
middle. It is estimated that a similar
proportion (50–70%) of PLCg that
translocates to the membrane becomes
associated with the vesicles. Bar, 10 mm.Matsuda et al. Imaging of PLCg Translocation 609
Discussion
To follow the cellular localization of PLCg in real time,
cells expressing PLCg containing a fluorescent tag were
stimulated by EGF known to activate this enzyme after
binding to EGFR (Schlessinger, 2000). After stimulation,
PLCg, which is in unstimulated cell present in the cyto-
plasm, undergoes several stages of subcellular redistribu-
tion, including fast but progressive attachment to the
plasma membrane, followed by concentration in areas of
extensive membrane ruffling and incorporation into intra-
cellular vesicular structures.
As shown in Results, the initial translocation first oc-
curred in some parts of the plasma membrane and then
spread to all areas where the receptor was present. This
Figure 9. Visualization of PI 4,5-P2 in growth factor stimu-
lated cells. (A) PC12 cells transfected with the isolated PH
domain from PLCd1 (GFP-d1PH) construct were stimulated
with NGF for 10 min and subsequently fixed and permeabi-
lized. The cells were stained using anti–PI 4,5-P2 antibody
and Texas red–conjugated secondary antibody (left) and
were also analyzed for the green fluorescence of the d1PH
domain construct (right). (B) A431 cells were analyzed 10
min after EGF stimulation as described in A, except that
the full-length catalytically inactive PLCd1 was used in-
stead of the isolated PH domain. (C) A431 cells transfected
with PLCg2-RFP were analyzed 10 min after EGF stimula-
tion. Staining with the anti–PI 4,5-P2 antibody was visual-
ized using FITC-conjugated secondary antibody (left), and
the red fluorescence of the PLCg2-RFP construct was ana-
lyzed (right). All enlarged areas also include a merge of red
and green fluorescence in a middle. Bar, 10 mm.The Journal of Cell Biology, Volume 153, 2001 610
gradual appearance at different parts of the membrane is
unlikely to be due to differences in the amounts of the re-
ceptor, since it could be observed in cells where the recep-
tor molecules containing the fluorescent tag were evenly
distributed around the membrane. Use of the deletion and
point mutations demonstrated that all determinants for
PLCg translocation to the plasma membrane are within
the region unique for the PLCg family, which is well con-
served between the two isoforms and is likely to involve
the function of both SH2 domains (Figs. 3 and 4). A re-
quirement for both SH2 domains of PLCg is consistent
with a previous in vitro binding study of isolated SH2 do-
mains to phosphorylated peptides from EGFR, suggesting
simultaneous binding to two different parts of the receptor
(binding of N-SH2 to pY1173 in the EGFR and binding of
C-SH2 to pY992 in the EGFR) (Chattopadhyay et al.,
1999). Furthermore, mutations in the N- or C-SH2 domain
abolished the interaction with the receptor and affected
the rate of PLCg phosphorylation in cells stimulated with
EGF (Chattopadhyay et al., 1999). However, the involve-
ment of only N-SH2 domain of PLCg in binding to the re-
ceptor or adapter proteins has been shown for signaling
via PDGF receptor (Ji et al., 1999; Poulin et al., 2000) and
B cell antigen receptor (DeBell et al., 1999). It was also
suggested that the functional C-SH2, although not re-
quired for the translocation, could be important for activa-
tion, leading to an increase in the rate of PI 4,5-P2 hydroly-
sis (DeBell et al., 1999; Ji et al., 1999). Evidence obtained
from an in vitro study of PLCg activity in the presence of
the PDGF receptor peptide supported the possibility that
binding to the receptor could cause allosteric changes and
stimulate PLC activity (Koblan et al., 1995). Thus, the role
of PLCg binding to the receptor via its SH2 domains may
not be restricted to translocation to the membrane and, to-
gether with PLCg phosphorylation, could contribute to
stimulation of PLCg activity. The colocalization of PLCg
and the receptor observed at early timepoints at the
plasma membrane, where the presence of the PI 4,5-P2
substrate can also be visualized, seem to coincide with the
peak of calcium responses, thus suggesting that the en-
zyme is fully active (Figs. 5, 7, and 10).
The experiments using the isolated gSA demonstrated
that it contains all of the determinants required for trans-
location. Together with the mutations in the N-PH do-
main, these data do not support the possibility that the PH
domain–mediated translocation precedes the interaction
with the receptor or contributes to the stability of the com-
plex, as suggested in earlier studies (Falasca et al., 1998).
Furthermore, possible interactions with PI 3,4,5-P3 by the
PH domain or through the C-SH2 domain shown in vitro
(Falasca et al., 1998) do not seem to be required for the
translocation, since this process has not been affected in
the presence of the PI 3-kinase inhibitor (Fig. 10 B). These
observations are consistent with earlier findings that the
PI 3-kinase inhibitors had no effect on PLCg phosphoryla-
tion and the enzyme–receptor complex formation de-
tected by coimmunoprecipitation (Falasca et al., 1998;
Poulin et al., 2000). However, it has been documented pre-
viously (Bae et al., 1998; Falasca et al., 1998; Rameh et al.,
1998) that wortmannin, LY294002, and dominant-negative
PI 3-kinase could cause reduction of I 1,4,5-P3 and calcium
responses to PDGF, suggesting that possible interactions
Figure 10. Effects of PI 3-kinase inhibitor LY294002. (A) Effects of PI
3-kinase inhibition on phosphorylation of PKB and EGFR in A431 cells were
followed after pretreatment with LY294002 for 40 min and subsequent stimu-
lation with 100 ng/ml EGF for 15 min. The phosphorylation of PKB was de-
tected by Western blotting using anti–phospho-PKB (Ser473) antibody at con-
centrations 0–50 mM LY294002 (left), whereas the effect of 50 mM LY294002
on phosphorylation of EGFR (resulting in some enhancement rather then in-
hibition) was monitored using antiphosphotyrosine antibody (right). (B) Ef-
fect of PI 3-kinase inhibition on translocation of PLCg2 was followed in A431
cells expressing the full-length PLCg2-RFP. The cells were treated with 50 mM
LY294002 for 40 min before EGF stimulation for 3 min (left). EGF-stimulated
A431 cells pretreated with LY294002 were analyzed using anti–PI 4,5-P2 anti-
body (right) as described in the legend to Fig. 9 B. (C) For intracellular Ca21
measurements, Fura-red–labeled A431 cells were incubated without (control)
or with 10 or 50 mM LY294002 (1LY) for 40 min at 378C, followed by the
stimulation with EGF (100 ng/ml) (arrows). The results shown are representa-
tive of average responses obtained by analyzing z20 individual cell for each
condition. Bar, 10 mm.Matsuda et al. Imaging of PLCg Translocation 611
between PI 3,4,5-P3 and PLCg may be important for acti-
vation. However, understanding of molecular basis and
specificity of this potential link would require further stud-
ies. Regarding the role of the N-PH domain, its contribu-
tion to this process could differ, depending on the specific
signaling pathway or PLCg isoform. In contrast to the sug-
gested involvement of this domain in PLCg1 signaling in
response to PDGF (Falasca et al., 1998), in B cells the mu-
tations in the PLCg2 PH domain (shown to block PI 3,4,5-
P3 binding to the PH domain of PLCg1) did not interfere
with the function of PLCg2 (Fig. 5 C).
In cells characterized by extensive ruffling prominent af-
ter several minutes of stimulation, PLCg, EGFR, and PI
4,5-P2 were all localized in the most dynamic areas at the
cell periphery (Figs. 8 and 9). Previous studies have sug-
gested that cytoskeletal proteins are included in these
structures. For example, the PI 4,5-P2–bound PLCd1 PH
domain and F actin colocalize in membrane ruffles (Tall et
al., 2000). Although there is no direct evidence, PLCg
could be bound to EGFR in these structures since PLCg
has not been detected in any parts of the membrane where
the receptor was not present (Fig. 8). The presence of the
substrate in the same structures (Fig. 9) suggests the possi-
bility that it could be hydrolyzed by the enzyme. Further-
more, earlier studies have demonstrated that only phos-
phorylated PLCg could hydrolyze PI 4,5-P2 bound to
profilin (Goldschmit-Clermont et al., 1991). However, this
potential hydrolysis of PI 4,5-P2 at later timepoints after
EGF stimulation is unlikely to contribute to calcium mobi-
lization and could be involved in PI 4,5-P2 functions re-
lated to the organization of the cytoskeleton. This PI 4,5-
P2/cytoskeleton link has been demonstrated in several
studies (Czech, 2000); however, the nature and molecular
aspects of this relationship have not been clarified.
Previous experiments using EGFR-GFP have enabled
studies of EGFR endocytosis and visualized fragile endo-
somal structures (Carter and Sorkin, 1998), circumventing
problems of immunocytochemistry. It has also been docu-
mented that EGFR is in these structures in the EGF-
bound form and highly phosphorylated (Carter and Sor-
kin, 1998; Wouters and Bastiaens, 1999). Furthermore, it
has been suggested that interactions with and activation of
several adapter and effector molecules (for example, com-
ponents of the Ras pathway) could be taking place in en-
dosomes (Baass et al., 1995; Bevan et al., 1996). Analysis
of the internalization of PLCg in the same cell-expressing
EGFR, demonstrated a similar pattern of endosomal
movements where swelling and fusion were taking place
followed by the formation of larger perinuclear structures
(Fig. 8). However, colocalization of PLCg and the recep-
tor may be only partial (Fig. 8), and PLCg appeared to be
completely separated from its substrate (Fig. 9). There-
fore, in the case of PLCg the incorporation into intracellu-
lar vesicles is likely to lead to downregulation of the en-
zyme activity. This is further supported by findings that
growth factor stimulation results in an early and transient
peak of calcium release (Fig. 10; Rameh et al., 1998; Poulin
et al., 2000). Several other observations are also consistent
with this possibility. For example, in cells defective in
endocytosis some signaling molecules that could serve
as a substrate in endosomes were underphosphorylated,
whereas PLCg was hyperphosphorylated, suggesting that
the main site of interaction and phosphorylation with
EGFR is in the plasma membrane (Vieira et al., 1996). In
another biochemical study, the formation of I 1,4,5-P3 in
response to growth factor stimulation was analyzed under
conditions where the EGFR internalized either as a
ligand–bound complex or largely free from the ligand
(Haugh et al., 1999). By comparing the ratio of activated
receptors at the cell surface and in the internalized com-
partment, it was concluded that only cell surface receptors
effectively participated in PLCg signaling.
In this study, the two PLCg isoforms were compared
(Figs. 1–3, 5, and 6) and found to be remarkably similar in
all aspects of EGFR-triggered translocation. Although
PLCg1 has been more extensively studied in this context,
it has been demonstrated that at least in transfected cells
both PLCg1 and PLCg2 can bind to and be activated by
growth factor receptors (Sultzman et al., 1991). Further-
more, studies of PLCg2 have shown that in addition to
high levels of expression in some hematopoietic cells, this
isoform is present in many different cell types and tissues
(Rebecchi and Pentyala, 2000). Therefore, it is possible
that both PLCg1 and PLCg2 could signal in pathways via
growth factor receptor and nonreceptor tyrosine kinases.
When isolated domains from PLCg1 and PLCg2 were
compared, again the gSA regions and the PH domains
demonstrated similarity between the isoforms (Figs. 3 and
5). In the case of the PH domains, as shown earlier for the
PLCg1 PH domain (Falasca et al., 1998), translocation can
be seen; however, translocation of isolated gSA region
from both isoforms followed kinetics of the full-length
proteins and further mutagenesis (not performed in the
study by Falasca et al., 1998) suggested that this part con-
tains all determinants that drive translocation. Further
comparative studies of the role for the PH domain in both
membrane interactions and activation are, however, re-
quired to fully understand the function of this domain in
each of the PLCg isoforms.
In conclusion, the data presented here obtained from
the real time fluorescence imaging have provided new
insights into a sequence of changes in subcellular local-
ization and function of PLCg after stimulation with
EGF. Together with experimental evidence obtained
previously using different experimental approaches,
the following model could be suggested. First, PLCg
undergoes rapid translocation to the plasma mem-
brane. This step requires direct interaction with the ac-
tivated receptor via the SH2 domains and leads to sub-
sequent stimulation of PLC activity, resulting in an
increase in the rate of PI 4,5-P2 hydrolysis present in
the membrane. PLCg, that still could be in a complex
with the receptor and active, is in some cells localized
in membrane ruffles that are prominent at later times
after stimulation. The internalization of PLCg into en-
dosome-like structures is likely to result in the down-
regulation of PLC activity, which may no longer have
access to its substrate.
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